IVBT.US Innovation1 Biotech Inc

Financial Services Biotechnology USA Stocks
0.0002 USD
Close of Jan 8, 2026
0.0002 0.0002
Market cap
USD 4.49K
P/E
-
P/B
0.36x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Feb 2024.

Is IVBT.US undervalued?

Graham number

The Graham number of Innovation1 Biotech Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Innovation1 Biotech Inc fundamental analysis

No fundamental analysis for Innovation1 Biotech Inc yet.

Innovation1 Biotech Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Innovation1 Biotech Inc

Innovation1 Biotech Inc. focuses on researching, developing, producing, and selling pharmaceutical products. The company offers natural supplements for the treatment of symptoms associated with the flu and long covid under the NutraFlu and Nutravid19 brands; and other supplement and medical nutrition products. It also develops NLC001 that is in Phase II clinical trial for the treatment of long covid and other viral indications. The company is based in New York, New York.

Full company profile